EXIDEIND.NS(EXIDEIND.NS)
EXIDEIND.NS
$420.85—Stale · unknown old
NSE • Last print unknown ago
$420.85—Stale · unknown old
No analyst ratings available
No analyst price targets available for EXIDEIND.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $197.26B | $215.23B | $228.10B | $245.32B |
| Low | $197.26B | $215.23B | $228.10B | $245.32B |
| High | $197.26B | $215.23B | $228.10B | $245.32B |
| EBITDA Avg | $27.64B | $32.10B | $36.01B | $45.85B |
| Low | $26.17B | $30.62B | $36.01B | $45.85B |
| High | $29.42B | $34.91B | $36.01B | $45.85B |
| EBIT Avg | $19.72B | $22.26B | $24.42B | $32.59B |
| Low | $18.25B | $20.78B | $24.42B | $32.59B |
| High | $21.49B | $25.07B | $24.42B | $32.59B |
| Net Income Avg | $13.95B | $15.88B | $17.51B | $23.71B |
| Low | $12.83B | $14.75B | $17.51B | $23.71B |
| High | $15.29B | $18.01B | $17.51B | $23.71B |
| EPS Avg | $16.41 | $18.68 | $20.61 | $27.90 |
| Low | $15.10 | $17.35 | $20.61 | $27.90 |
| High | $18.00 | $21.19 | $20.61 | $27.90 |
| Analysts (Rev / EPS) | 14 / 12 | 16 / 16 | 10 / 9 | 10 / 9 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $47.83B | $46.23B | $49.59B |
| Low | $47.22B | $45.32B | $48.78B |
| High | $48.45B | $47.15B | $50.40B |
| EBITDA Avg | $6.04B | $5.70B | $6.49B |
| Low | $5.95B | $5.62B | $6.40B |
| High | $6.13B | $5.78B | $6.59B |
| EBIT Avg | $4.49B | $4.05B | $4.72B |
| Low | $4.40B | $3.97B | $4.62B |
| High | $4.58B | $4.13B | $4.81B |
| Net Income Avg | $3.23B | $2.89B | $3.40B |
| Low | $3.16B | $2.83B | $3.33B |
| High | $3.30B | $2.95B | $3.47B |
| EPS Avg | $3.80 | $3.40 | $4.00 |
| Low | $3.72 | $3.33 | $3.92 |
| High | $3.88 | $3.47 | $4.08 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 |